SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-091503
Filing Date
2020-08-06
Accepted
2020-08-06 17:01:12
Documents
56
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020466-1_10q.htm 10-Q 566332
2 EXHIBIT 31.1 tm2020466d1_ex31-1.htm EX-31.1 11093
3 EXHIBIT 32.1 tm2020466d1_ex32-1.htm EX-32.1 4574
4 GRAPHIC image_004.jpg GRAPHIC 26360
  Complete submission text file 0001104659-20-091503.txt   4352624

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT syn-20200630.xml EX-101.INS 1049399
6 XBRL TAXONOMY EXTENSION SCHEMA syn-20200630.xsd EX-101.SCH 38538
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20200630_cal.xml EX-101.CAL 37335
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20200630_def.xml EX-101.DEF 177945
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20200630_lab.xml EX-101.LAB 305994
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20200630_pre.xml EX-101.PRE 276286
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 201082592
SIC: 2834 Pharmaceutical Preparations